Behavioral Symptoms: Clinical Trials

552 trials for Behavioral Symptoms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

370 completed, 60 unknown, 47 terminated, 31 recruiting. 552 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4552Completed 370, Unknown 60, Terminated 47, Recruiting 31, Withdrawn 24, Not yet recruiting 11, Active not recruiting 7, Enrolling by invitation 1, Suspended 1

Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms

Trials (filtered) newest first · largest first

All 552 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus
Phase 4Not yet recruitingEunice Dube21402027-01-302026-07-30
Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder
Lurasidone (Latuda) - Bipolar Disorder Depression
Phase 4Not yet recruitingMartin Lan602026-11-012026-09-08
Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial
Esketamine combined with dexmedetomidine, Dexmedetomidine - Dexmedetomidine, Ketamine
Phase 4Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University3562026-09-282026-09-03
The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
Lumateperone 42 mg - Bipolar Depression Depressed Phase, Obesity & Overweight
Phase 4RecruitingMassachusetts General Hospital252026-09-092026-09-11
Dexmedetomidine-Esketamine Combination on Depression and Anxiety After Laparoscopic Ureteral Reconstruction
Combined dexmedetomidine-esketamine administration, Placebo administration - Ureteral Stricture, Dexmedetomidine
Phase 4Not yet recruitingPeking University First Hospital6582026-08-012026-08-14
Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Deutetrabenazine Oral Capsule - Tardive Dyskinesia, Intellectual Disability
Phase 4RecruitingUniversity Hospitals Cleveland Medical Center252026-06-222026-07-06
Esketamine Versus Crisis Response Planning Versus Enhanced Treatment as Usual for Suicide Prevention: A Pragmatic Randomized Trial in a Brazilian Municipality (SAVE)
Intravenous Esketamine, Crisis Response Planning (CRP), Enhanced Treatment as Usual (eTAU) - Suicide Prevention, Ketamine
Phase 4RecruitingUniversity of Sao Paulo4782026-06-012026-09-16
Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression
Esketamine-dexmedetomidine combination, Placebo - Parturients, Depressive Symptoms
Phase 4Not yet recruitingPeking University First Hospital1642026-06-012026-06-15
Comprehensive Toileting Program
Glycerin Suppository, Behavioral strategies - Encopresis, ASD
Phase 4RecruitingEmory University1502026-06-012026-06-18
Self-hangIng Patient and Hyperbaric Oxygen Therapy _ SIPHON Study
OXYGENE MEDICINAL LIQUIDE AIR PRODUCTS MEDICAL - Suicide
Phase 4Not yet recruitingUniversity Hospital, Lille502026-06-012026-05-22
The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression
Esketamine, Dexmedetomidine - Depressed, Bariatric Surgery
Phase 4Active not recruitingThe First Hospital of Jilin University402026-05-012026-05-08
Comparing Acupuncture With Medication to Reduce Depression, Anxiety and Comorbid Sleep Disorders in China
Psychotropic Drugs, Acupuncture - Anxiety Depression, Sleep
Phase 4RecruitingDuke Kunshan University1802026-04-012026-07-29
Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia
Clostridium butyricum, placebo - Functional Dyspepsia, Probiotics
Phase 4RecruitingXijing Hospital of Digestive Diseases1802026-03-262026-10-13
Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants
CNS Stimulant, Placebo, CNS Stimulant open label first phase - ADHD - Attention Deficit Disorder With Hyperactivity, Irritability
Phase 4RecruitingMilton S. Hershey Medical Center1362026-03-052026-04-20
Discontination of Antidepressants in Remitted Depression
Hyperbolic tapering, Linear tapering - Depression - Major Depressive Disorder
Phase 4Not yet recruitingUniversita di Verona1502026-02-012026-02-06
Esketamine With or Without Integration Therapy for Treatment-Resistant Depression
Esketamine hydrochloride (intranasal), Integration Therapy - Treatment-resistant Depression (TRD)
Phase 4RecruitingUniversity of Puerto Rico202026-02-012026-01-27
Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant
Combination of methotrexate and escitalopram in treatment of psoriasis patients with depression and/or anxiety, Methotrexate - Depression, Anxiety
Phase 4CompletedCairo University402026-02-012026-10-05
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
Ketamine, standard general anesthesia - Orthopedic Trauma Surgery Patients, Postoperative Pain
Phase 4RecruitingTexas Tech University Health Sciences Center902025-11-062026-03-24
Clinical Study of Compound Ciwujia Granules in the Treatment of Depression
Compound Ciwujia Granules, placebo - Depression - Major Depressive Disorder, Depression Disorders
Phase 4Active not recruitingShanghai Mental Health Center602025-10-012026-04-23
Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients
Metformin Hydrochloride - Depression
Phase 4RecruitingFazaia Ruth Pfau Medical College1402025-10-012025-09-19

Showing 20 of 552. Sign in to see all of them.

Narrower conditions

Depression (437)  ·  Depressive Disorder, Major (125)  ·  Psychomotor Agitation (48)  ·  Bipolar Disorder (45)  ·  Anxiety Disorders (42)  ·  Depressive Disorder (38)  ·  Psychotic Disorders (19)  ·  Aggression (17)  ·  Suicidal Ideation (17)  ·  Mood Disorders (16)  ·  Schizophrenia (16)  ·  Suicide (15)  ·  Cognitive Dysfunction (13)  ·  Alzheimer Disease (12)  ·  Depressive Disorder, Treatment-Resistant (12)

Broader conditions

Behavior (548)  ·  Mental Disorders (331)  ·  Mood Disorders (185)  ·  Pathological Conditions, Signs and Symptoms (149)  ·  Signs and Symptoms (130)  ·  Depressive Disorder (128)  ·  Nervous System Diseases (128)  ·  Neurologic Manifestations (102)  ·  Neurobehavioral Manifestations (78)  ·  Aberrant Motor Behavior in Dementia (61)  ·  Dyskinesias (50)  ·  Psychomotor Disorders (48)  ·  Bipolar and Related Disorders (45)  ·  Central Nervous System Diseases (42)

Interventions

Escitalopram (71)  ·  Sertraline (44)  ·  Ketamine (29)  ·  Duloxetine Hydrochloride (28)  ·  Venlafaxine Hydrochloride (26)  ·  Fluoxetine (22)  ·  Citalopram (21)  ·  Bupropion (20)  ·  Sugars (19)  ·  Paroxetine (18)  ·  Saline Solution (18)  ·  Quetiapine Fumarate (16)  ·  Dexmedetomidine (15)  ·  Lithium (12)  ·  Risperidone (12)

Sponsors

New York State Psychiatric Institute (33)  ·  Massachusetts General Hospital (24)  ·  Emory University (16)  ·  University of Pittsburgh (15)  ·  University of California, Los Angeles (14)  ·  Indiana University (11)  ·  University of North Carolina, Chapel Hill (8)  ·  Eli Lilly and Company (7)  ·  National Institute of Mental Health (NIMH) (7)  ·  University of Pennsylvania (7)  ·  University of Texas Southwestern Medical Center (7)  ·  Stanford University (5)  ·  Sunnybrook Health Sciences Centre (5)  ·  University of Cincinnati (5)  ·  Weill Medical College of Cornell University (5)

Countries

United States (316)  ·  Canada (38)  ·  China (28)  ·  Germany (16)  ·  Denmark (13)  ·  South Korea (13)  ·  Italy (12)  ·  Israel (11)  ·  France (10)  ·  Netherlands (9)  ·  Australia (8)  ·  Egypt (8)  ·  Spain (7)  ·  Switzerland (7)  ·  Brazil (6)

Top investigators

Amit Anand, MD (8)  ·  David J. Hellerstein, MD (4)  ·  Warren D Taylor, MD, MHSc (4)  ·  Helen Lavretsky, M.D. (3)  ·  Jennifer Felger, PhD (3)  ·  Michael E Henry, MD (3)  ·  Bret Rutherford, MD (2)  ·  Carl Gommoll, MS (2)  ·  Charles Bowden, MD (2)

Results publications

PMID 33884617, PMID 25080392, PMID 24144505, PMID 26803397, PMID 29608461, PMID 30358242, PMID 30524702, PMID 36999619, PMID 37952772, PMID 40728007, PMID 10074879, PMID 10534584, PMID 11110112, PMID 11442853, PMID 12377400, PMID 12874492, PMID 1438661, PMID 14639062, PMID 14996777, PMID 15800144, PMID 15910213, PMID 15956269, PMID 16009352, PMID 16166403, PMID 16168037, PMID 16247923, PMID 16390886, PMID 16426099, PMID 16457894, PMID 16540613, PMID 16551710, PMID 16554525, PMID 16554526, PMID 16566612, PMID 16566901, PMID 16636629, PMID 16642436, PMID 16690084, PMID 16754414, PMID 16772623, PMID 16816220, PMID 16824617, PMID 16946176, PMID 16946177, PMID 16974189, PMID 17017829, PMID 17074942, PMID 17091129, PMID 17195602, PMID 17229469

NIH funding

2005 (3), 2009 (2), 2018 (2), 5UL1TR001420-03 (2), K23MH067710 (2), K23MH076049 (2), R01MH060353 (2), R01MH061017 (2), R01MH072383 (2), 1KL2RR025015-01 (1), 2008 (1), 2016 (1), 2019 (1), 2023 (1), K01MH095920 (1)